Imaging study for brain tumors using PET and MRI
Part of Cancer clinical trials.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be part of the main study (IRB 300007756).
- You must be 18 years or older.
- You must be able to have PET and MRI scans without anesthesia (light sedation is okay).
- If you are a woman who can have children, you must have a negative pregnancy test.
- You must be able to perform daily activities with some help (ECOG score of 2 or better).
- You must have a life expectancy of more than 12 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This study checks how well an FDOPA PET scan can identify and describe a specific type of brain tumor at the beginning. Results may help doctors decide on the best next steps for diagnosis and treatment planning.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
This trial tests a special PET scan tracer (18F-FET) to see if it can help doctors better identify and plan treatment for brain tumors. It may be an option if you are scheduled for surgery for a suspected new glioma.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.